There are 717 resources available
Optimal combinations of systemic therapies in treatment-naïve patients with advanced hormone-sensitive prostate cancer: Which ones and for which patients?
Presenter: Arnulf Stenzl
Session: ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer
Resources:
Slides
Webcast
How do modern first-line combination regimens affect the therapeutic algorithm in later lines of therapy in metastatic prostate cancer?
Presenter: Karim Fizazi
Session: ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer
Resources:
Slides
Webcast
State of the art therapeutic landscape in non-metastatic castration-resistant prostate cancer
Presenter: Wai Kay Kwong
Session: ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer
Resources:
Slides
Webcast
Emerging systemic therapies in unresectable bladder cancer: Immunotherapy, kinase inhibitors and antibody-drug conjugates
Presenter: Matthew Galsky
Session: ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer
Resources:
Slides
Webcast
Molecular profiles of “actionable” aberrations in endometrial and ovarian cancer: The dawn of precision medicine
Presenter: Ignacio Romero
Session: ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer
Resources:
Slides
Webcast
The promise of immune checkpoint inhibitors in endometrial cancer
Presenter: Ana Oaknin
Session: ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer
Resources:
Slides
Webcast
Treatment benefit from PARP inhibitors and resistance mechanisms in patients with advanced epithelial ovarian cancer: State of the art and new concepts
Presenter: Mansoor Raza Mirza
Session: ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer
Resources:
Slides
Webcast
Emerging combinations of immune checkpoint inhibitors with targeted agents in ovarian and endometrial carcinomas
Presenter: Antonio Jose Gonzalez Martin
Session: ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer
Resources:
Slides
Webcast
Key messages and wrap up
Presenter: Jonathan Ledermann
Session: ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer
Resources:
Slides
Webcast
Q&A, live discussion and wrap up
Presenter: Ravindran Kanesvaran
Session: ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer
Resources:
Webcast